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Abstract The biosynthetic gene cluster of porothramycin, a
sequence-selective DNA alkylating compound, was identified
in the genome of producing strain Streptomyces albus subsp.
albus (ATCC 39897) and sequentially characterized. A 39.7 kb
long DNA region contains 27 putative genes, 18 of them
revealing high similarity with homologous genes from biosyn-
thetic gene cluster of closely related pyrrolobenzodiazepine
(PBD) compound anthramycin. However, considering the
structures of both compounds, the number of differences in
the gene composition of compared biosynthetic gene clusters
was unexpectedly high, indicating participation of alternative
enzymes in biosynthesis of both porothramycin precursors,
anthranilate, and branched L-proline derivative. Based on the
sequence analysis of putative NRPSmodules Por20 and Por21,
we suppose that in porothramycin biosynthesis, the methyla-
tion of anthranilate unit occurs prior to the condensation reac-
tion, while modifications of branched proline derivative, oxi-
dation, and dimethylation of the side chain occur on already
condensed PBD core. Corresponding two specific methyltrans-
ferase encoding genes por26 and por25 were identified in the
porothramycin gene cluster. Surprisingly, also methyltransfer-
ase gene por18 homologous to orf19 from anthramycin bio-
synthesis was detected in porothramycin gene cluster even
though the appropriate biosynthetic step is missing, as sug-
gested by ultra high-performance liquid chromatography-diode
array detection-mass spectrometry (UHPLC-DAD-MS) analy-
sis of the product in the S. albus culture broth.
Introduction
Pyrrolobenzodiazepines (PBDs) are sequence-selective
DNA alkylating compounds exhibiting weak antimicrobial
but remarkable anticancer effects. The spectrum of biolog-
ical activities of the naturally produced PBDs encouraged
the chemical synthesis of variety of PBDs, including dimer-
ic and hybrid ones, resulting in improvement of the DNA-
binding sequence specificity and the antineoplastic potency
of this class of compounds (Gerratana 2012). However,
PBDs have also a potential from another biotechnological
point of view: The biosyntheses of most PBDs and com-
mercially used antibiotic lincomycin have a common pre-
cursor, the unusual branched proline derivative (red in
Fig. 1) synthesized from L-tyrosine (Brahme et al. 1984).
Among lincomycin derivatives, both the length and modi-
fication of the alkyl side chain of proline moiety remarkably
affect the antimicrobial activity (Magerlein 1977). The
preparation of such more efficient lincomycin derivatives
by mutasynthesis has been already described (Ulanova et al.
2010). Thus, an appropriate combination of biosynthetic
gene clusters of PBDs and lincomycin can yield producing
strains of hybrid lincosamide derivatives with improved
biological properties.
The comparison of three already sequenced PBD biosyn-
thetic gene clusters (Hu et al. 2007; Li et al. 2009a; Li et al.
2009b) and the lincomycin one (Koberska et al. 2008) reveals
five or six shared homologous genes coding for enzymes
converting L-tyrosine to branched L-proline derivative. In
accordance with the compound structures, the sibiromycin
and especially anthramycin biosynthetic gene clusters contain
additional genes encoding further modifications of the proline
moiety side chain. Based on the porothramycin structure
(Tsunakawa et al. 1988), its biosynthetic gene cluster is ex-
pected to contain the largest set of the proline moiety modi-
fying genes.
L. Najmanova (*) :M. Jelinkova : Z. Kamenik : E. Kettnerova :
M. Koberska : R. Gazak : B. Radojevic : J. Janata




Present address: Oceanography Section, Science Research Center,
Kochi University, Kochi, Japan
Folia Microbiol (2014) 59:543–552
DOI 10.1007/s12223-014-0339-x
According to the presence/absence of the hydroxyl group
in position 3 of anthranilate moiety, two distinct biosynthetic
pathways have been described among PBD-producing strains:
the chorismate pathway resulting in anthranilic acid, a precur-
sor of tomaymycin biosynthesis, and the kynurenine pathway
resulting in 3-hydroxyanthranilic acid, incorporated by appro-
priate NRPS into sibiromycin or anthramycin structure (Li
et al. 2009b). The position of the hydroxyl group in
porothramycin and anthramycin is identical, assigning
porothramycin among PBDs employing the kynurenine type
of anthranilate moiety biosynthesis. The composition of genes
in porothramycin biosynthetic gene cluster thus should resem-
ble mostly the anthramycin one, differing just in the presence/
absence of three or four methyltransferase genes.
In this paper, the porothramycin biosynthetic gene cluster
was sequentially characterized, compared to earlier reported
biosynthetic gene clusters of PBDs (anthramycin,
sibiromycin, and tomaymycin) and the unexpected gene com-
position is discussed.
Materials and methods
Genomic library construction and screening
Chromosomal DNA was isolated from Streptomyces albus
subsp. albus (ATCC 39897) mycelia grown on orbital shaker
in yeast extract-malt extract (YEME) broth (50 mL in a
250-mL flask) containing 0.5 % glycine, according to method
described by Hopwood et al. (1985) and modified by
Vachalova et al. (1995). The DNAwas partially digested with
BamHI (New England Biolabs) to yield DNA fragments 40–
60 kbp and ligated into SuperCos I cosmid vector (Stratagene).
The cosmid vector was previously linearized with XbaI (New
England Biolabs), treated with calf intestine alkaline phospha-
tase and digested with BamHI (both New England Biolabs).
The resulting ligation mixture was packaged into the λ phage,
followed by phage transfection into Escherichia coliXL1-Blue
MRb strain by using protocols of Gigapack III XL Packaging
Kit (Stratagene). Isolation of the cosmids was carried out on
NucleoBond BAC 100 columns (Macherey-Nagel).
The S. albus cosmid library was screened by colony PCR
using a pair of degenerate primers P1For/P1Rev (Table 1),
designed based on the sequence comparison of the
anthramycin, sibiromycin, and tomaymycin gene clusters
(GenBank accession numbers EU195114, FJ768674, and
FJ768957). The primers resemble the conserved sequence of
genes encoding NRPS and kynurenine-3-monooxygenase, re-
spectively. The cosmid CP4 from a positive clone contained 10
open reading frames (ORFs) exhibiting high similarity to al-
ready described PBD genes. However, the ORF sequence
homologous to orf7 from anthramycin biosynthesis was clearly
truncated. Another pair of primers P2For/P2Rev designed ac-
cording to the sequence of truncated orf7 homologwas used for
Fig. 1 Chemical structures of porothramycin, lincomycin, and PBDs
with published biosynthetic gene clusters. The branched proline deriva-
tive of a common origin is in red. The position modifications which differ
in structures of porothramycin and its closest relative anthramycin are
marked in circles
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additional S. albus library screening to isolate cosmid CP16
harboring the remaining part of the porothramycin gene cluster.
DNA sequencing and analysis
The cosmid DNA was sequenced at the DNA Sequencing
Facility, University of Cambridge, UK, by a shotgun approach
and subsequent primer walking to cover the gaps. The CP4
and CP16 sequences were assembled into contig using
Geneious 5.3.4. software (Biomatters). The putative genes
were predicted using SoftBerry online tool (www.softberry.
com) and edited based on homology with already sequenced
PBD gene clusters or closely related genes searched by
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The BlastX
was used also for prediction of putative functions of encoded
proteins. The gene cluster localization in the chromosomewas
assessed using the BioCyc collection of pathway/genome
databases at http://biocyc.org/. Nonribosomal codes were
estimated by NRPSpredictor 2 at http://nrps.informatik.uni-
tuebingen.de/ (Rottig et al. 2011).
Nucleotide sequence accession number
The sequence of the porothramycin gene cluster has been
deposited in GenBank under accession number HQ872605.
Production of porothramycin
Spores of S. albus subsp. albus (ATCC 39897) were inocu-
lated in YEME broth (50 mL) and cultivated in an orbital
shaker for 24 h at 28 °C. Then, 50 mL of fresh AVM broth
(yeast extract 2 g/L, (NH4)2SO4 2 g/L, CaCO3 5 g/L, NaCl
2 g/L, K2HPO4 0.5 g/L, FeSO47H2O 0.05 g/L, ZnSO4 7H2O
0.05 g/L, MnSO4 7H2O 0.05 g/L, MgSO4 7H2O 0.1 g/L,
glucose 30 g/L) was inoculated with 5 % of the pre-culture
and cultivation continued for 240 h at 28 °C. Cells were
harvested by centrifugation for 10 min at 4 °C, and the
supernatant was used for solid-phase extraction.
Solid-phase extraction (SPE)
Oasis HLB 3 cc 60 mg SPE cartridge (Waters, USA) was
conditioned with 3 mL methanol, equilibrated with 3 mL
water, and then, 3 mL cultivation broth was loaded. Subse-
quently, the cartridge was washed with 3 mL water, and
absorbed substances were eluted with 1.5 mL methanol. The
eluent was evaporated to dryness, reconstituted in 150 μL
50 % methanol, and centrifuged at 13,000 rpm for 5 min.
The crude extract was analyzed by ultra high-performance
liquid chromatography (UHPLC) with diode array detection
(DAD) detection. For mass spectrometry (MS) detection, the
crude extract was diluted 10× with 50 % methanol.
UHPLC-DAD-MS analysis
The crude extract was analyzed on Acquity UPLC system with
LCT premier XE time of flight MS analyzer (Waters). The
UHPLC column Acquity UPLC BEH C18 (50 mm×2.1 mm
I.D., particle size 1.7μm,Waters) and a two-component mobile
phase were used for the separation. The mobile phase parts A
and B consisted of 0.1 % formic acid (99 %, Merck, Germany)
in water and 0.1 % formic acid in methanol (99.95 %,
Chromapur GG, Chromservis, Czech Republic), respectively.
The analyses were performed using a linear gradient program
(min/%B) 0/5, 1.5/5, 15/90 followed by a 2-min column clean
up (99 % B) and a 2-min equilibration (5 % B). The total
analysis time was 19 min. The column temperature was set at
40 °C, flow rate at 0.4 mL/min, and the injection volume was
5 μL. The DAD detector acquired data from 210 to 600 nm
with data sample rate 20 points per second and filter constant
0.5. The MS detector operated in the “W” positive mode with
capillary voltage set at 2,800V; cone voltage, 40 V; desolvation
gas temperature, 350 °C; ion source block temperature, 120 °C;
cone gas flow, 50 L/h; desolvation gas flow, 800 L/h; ion guide
1 and 2 RFs, 200 and 300 V, respectively; and hexapole RF,
150 V. The aperture 1 value was set at 0 Vor at 50 V when the
fragmentation by collisionally induced dissociation (CID) was
carried out. The signal was acquired with the scan time, 0.1 s;
interscan delay was 0.01 s (0.1 s for lock spray). The mass
accuracy was kept below 5 ppm using lock spray technology
with leucine enkephalin as the reference compound (2 ng/μL,
5 μL/min). The data were processed by MassLynx V4.1 soft-
ware (Waters). The chromatograms were extracted at the m/z
corresponding to the analyte theoretical mass; the tolerance
window was ±0.015 Da.
Results
The assignment of the porothramycin gene cluster
from S. albus (ATCC 39897)
The two overlapping cosmid sequences CP4 and CP16 were
assembled to give a continuous sequence of 54 kb saved in
GenBank database including 39.7-kb region with 27 open
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reading frames (named por1–por27) identified and tentatively
assigned to the porothramycin gene cluster by sequence anal-
ysis (Fig. 2, Table 2). The five ORFs upstream por1 were
named orf1–5, and another two open reading frames down-
stream por27 were named orf6 and orf7.
Eighteen out of 27 por genes resemble significant similar-
ity to genes from anthramycin biosynthetic gene cluster and
many of them also to other PBD biosynthetic gene clusters.
Remaining nine por genes were assigned to porothramycin
biosynthesis based on the position in the gene cluster or
according to the proposed function of the respective proteins.
Estimation of borders and localization of the gene cluster
in genome
Three putative ORFs upstream of por1 (orf1–3) are similar to
fragments of IS116/IS110/IS902 family transposases indicat-
ing probable place of gene cluster integration into the genome.
Other two following putative ORFs (orf4 and orf5) exhibit
only partial and very low sequence similarity to transcriptional
regulators, making any prediction of putative function impos-
sible. Thus, the gene por1, coding for putative NADPH-
dependent FMN reductase probably supporting one or two
monooxygenases encoded by genes por23 and por27, was
assigned to be the first coding sequence of the porothramycin
gene cluster. The orf6 immediately downstream of por27
codes for putative protein, exhibiting ~80 % identity to
endoglycoceramidases, the enzymes hydrolyzing a β-
glycosidic linkage between oligosaccharides and ceramides
in various glycosphingolipids. In the porothramycin biosyn-
thetic pathway, no such activity is expected indicating por27
to be the last gene of porothramycin gene cluster.
In order to localize the porothramycin biosynthetic gene
cluster position in the chromosome, the sequences of
~4,500 nt upstream of por1 and ~7,000 nt downstream of
por27 were compared with the already sequenced genome of
nonproducing strain S. albus J1077 (GenBank accession num-
ber CP004370.1). However, no similarity was detected, indi-
cating that the probable position of the gene cluster is in one of
the terminal arms of the chromosome. Further, this hypothesis
was supported by the sequence comparison with other already
sequenced streptomycete genomes using the BioCyc tools.
The genes homologous to the orf6 downstream of por27
(coding for putative endoglycoceramidase) are, when present,
localized mostly in one of the terminal arms of the
chromosome (S. avermitilis, S. bingchenggensis BCV-1,
S. hygroscopicuc jingganensis 5008, or S. scaibei 87.82).
Comparative analysis of porothramycin biosynthetic gene
cluster
As expected, the highest number of homologs of 27 por genes,
18, can be found in the anthramycin biosynthetic gene cluster.
Moreover, with only three exceptions, the encoded proteins
from anthramycin biosynthesis are the closest homologs of the
porothramycin ones. On the other hand, the number of iden-
tified differences in the gene composition is unexpectedly
high. Based on the compound structures, only the presence
of 2–3 porothramycin-specific methyltransferase genes and
absence of orf19 homolog coding anthramycin-specific meth-
yltransferase were supposed. Surprisingly, the orf19 homolog
was detected in porothramycin gene cluster (por18), while
homologs of another six anthramycin genes (orf2, orf3, orf8,
orf11, orf17, and orf18) were not. Additionally, homologs of
nine porothramycin genes (por1, por3, por4, and por22–
por27) are not present in the anthramycin gene cluster.
The absence of three anthramycin homologs in the
porothramycin gene cluster can be easily explained:
orf11 and orf18 are too short without any assigned func-
tion. The porothramycin gene cluster sequence thus indi-
cates that the definition of these ORFs was probably
artificial. The orf8 encodes the resistance determinant of
ATP-binding cassette (ABC) transporter family. The
porothramycin-specific gene por3 codes for a putative
ABC transporter of UvrA family, probably exhibiting
similar function to the orf8 product.
The absence of other three anthramycin homologs reflects
unexpected differences in the biosynthesis of both building
units, anthranilate (orf17) and branched proline derivative
(orf2 and orf3). The orf17 codes for tryptophan 2,3-
dioxygenase (TDO) catalyzing the first reaction of kynurenine
pathway leading to one of final compound precursors, 3-
hydroxyanthranilic acid. The orf2 and orf3 genes code for
dehydrogenases which are supposed to oxidize side chain of
branched proline derivative precursor. We suggest that three
porothramycin specific genes (por1, por23, and por27) could
replace the missing orf2 and orf3 homologs in the alternative
pathway leading to branched proline derivative. The proposed
modifications of both precursors’ biosynthetic pathways will
be discussed.
Fig. 2 Biosynthetic gene cluster for porothramycin. The 27 por genes
assigned to the porothramycin biosynthetic gene cluster are in gray color
marked by respective numbers; the 18 genes homologous to the
anthramycin ones are highlighted. The ORFs upstream por1 and down-
stream por27, orf1–orf7 are marked o1–o7. The arrangement of overlap-
ping cosmids CP16 and CP4 is shown below
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The presence of two out of five remaining porothramycin
specific genes, por25 and por26 coding for methyltransfer-
ases, was predicted. According to BlastX analysis, the por26
product putatively catalyzes O-methylation of porothramycin
C-9 hydroxyl while putative aminomethyltransferase Por25
could be responsible for dimethylation of proline derivative
building unit side chain. The presence of remaining two
putative regulatory genes (por4 and por22) and putative glu-
tamine synthetase gene (por24) was not expected but could be
consistent with the proposed biosynthetic pathway and will be
discussed.
Two putative NRPS coding genes por20 and por21 were
identified. The por20 is homologous to NRPS coding gene
orf21 from anthramycin biosynthesis responsible for anthrani-
late building unit activation. According to BlastX analysis, the
5,817 nt long por21 seems to be a fusion gene coding for NRPS
and kynurenine 3-monooxygenase. The respective NRPS part
is homologous to ORF22 from anthramycin biosynthesis,
which is responsible for recognition and activation of proline
derivative building block and condensation reaction. Respec-
tive kynurenine 3-monooxygenase is homologous to ORF23,
catalyzing the third reaction of kynurenine pathway.
The NRPS adenylation domain (A-domain) activates the
NRPS substrate for further condensation. The A-domain sub-
strate binding pocket is formed by a set of 10 amino acid
residues, often called the “nonribosomal code”, which side
chains contact the substrate (Conti et al. 1997; Stachelhaus
et al. 1999) and thus determine the substrate specificity of A-
domains. Analysis of the nonribosomal code of an
uncharacterized A-domain can thus often predict its substrate
specificity. Comparison of both Por20 and Por21
nonribosomal codes with their respective homologs from
anthramycin and sibiromycin biosynthesis is shown inTable 3.
According to BlastX analysis of full-length NRPS modules,
Table 2 ORF analysis of porothramycin biosynthetic gene cluster










por1 177 YP_003114518 66/80 NADPH-dependent FMN reductase
por2 227 AFU02188 68/77 two component transcriptional regulator ORF25 (ABW71856) 66/77
por3 743 WP_020540464 75/86 ABC transporter (UvrA family)
por4 316 WP_019357233 75/83 DeoR family transcription regulator
por5 479 ABW71855 70/81 flavin-containing oxidoreductase ORF24 (ABW71855) 70/81
por6 400 ABW71841 70/82 MFS transporter ORF10 (ABW71841) 70/82
por7 258 ABW71840 61/72 hydroxylase/glyoxylase
(bleomycin res)
ORF9 (ABW71840) 61/72
por8 622 ABW71832 72/81 amidotransferase ORF1 (ABW71832) 72/81
por9 397 ABW71835 73/83 cytochrome P450 hydroxylase ORF4 (ABW71835) 73/83
por10 350 ABW71836 76/86 C-Methyltransferase ORF5 (ABW71836) 76/86
por11 599 ABW71837 81/87 gamma-glutamyltransferase ORF6 (ABW71837) 81/87
por12 471 ABW71838 73/82 FAD oxidoreductase ORF7 (ABW71838) 73/82
por13 156 ABW71843 72/83 L-DOPA 2,3-dioxygenase ORF12 (ABW71843) 72/83
por14 305 ABW71844 61/70 L-Tyrosine 3-hydroxylase ORF13 (ABW71844) 61/70
por15 297 ABW71845 82/88 F420 dependent reductase ORF14 (ABW71845) 82/88
por16 289 ABW71846 65/71 unknown (putative isomerase) ORF15 (ABW71846) 65/71
por17 415 ABW71847 75/81 kynureninase ORF16 (ABW71847) 75/81
por18 347 YP_006809167 73/85 aromatic C-methyltransferase ORF19 (ABW71850) 73/81
por19 288 WP_017545377 71/76 aryl formamidase ORF20 (ABW71851) 74/80
por20 607 ABW71852 73/84 NRPS ORF21 (ABW71852) 73/84
por21 1938 ABW71853+
ABW71854
71/80+72/81 NRPS+kynurenine 3-monooxygenase ORF22 (ABW71853)+
ORF23 (ABW71854)
71/80+72/81
por22 290 WP_017974834 67/77 NmrA family transcriptional regulator
por23 477 WP_005249919 76/86 FMNH2-dependent monooxygenase
por24 445 ABZ09841 65/75 glutamine synthetase
por25 807 WP_003888341 63/76 Aminomethyltransferase
por26 352 WP_010304927 69/79 O-methyltransferase
por27 448 WP_005445166 73/85 Flavin-containing monooxygenase FMO
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Por20 was found to be the closest relative of ORF21 with
significantly higher homology when compared to SibE from
sibiromycin biosynthesis (Table 3(A)). However, when com-
paring the nonribosomal codes only, ORF21 and SibE are
identical, whereas Por20 differs in three amino acid residues,
indicating that the recognized anthranilate precursor of
porothramycin probably differs from that of anthramycin
and sibiromycin. On the other hand, only a single difference
between nonribosomal codes of Por21 and ORF22 indicates
identical or nearly identical proline derivative precursors in
biosyntheses of porothramycin and anthramycin. These out-
puts enable to predict the substrates of condensation reaction
as discussed later.
UHPLC-DAD-MS analysis of porothramycin
The culture broth of S. albus was purified by solid-phase
extraction, and the crude extract was analyzed by UHPLC-
DAD-MS. The analysis revealed an ion-extracted chromato-
graphic peak of the porothramycin methoxy form at the re-
tention time of 7.49 min. The corresponding mass spectrum
(Fig. 3a) shows the major peak of 358.1766, which is in
accordance with the theoretical value of 358.1768 for the
[M+H]+ adduct of porothramycin methoxy form. These data
were further supported by the fragmentation pattern in the
CID mass spectrum (Fig. 3b). In addition, the UV spectrum
of this compound exhibited a maximum at 335 nm (Fig. 3c),
which complies with data that have been reported for
porothramycin (Tsunakawa et al. 1988). To sum up, the high
resolution mass spectrometry data, including the fragmenta-
tion pattern of CID mass spectrum and the UV spectrum
provide very convincing evidence that the culture broth of
S. albus contained the porothramycin.
Porothramycin forms
All PBDs including porothramycin can be found in three
different forms, depending on storage or analysis conditions.
The imine and carbinolamine forms are in equilibrium in
aqueous solutions, whereas the methoxy form is formed in
methanol and is in equilibrium with the carbinolamine form
(Barkley et al. 1991; Petrusek et al. 1981; Hurley et al. 1988;
Remers et al. 1986; Leimgrub et al. 1965). We have detected
the porothramycin byMS as the porothramycin methoxy form
(see the chemical structure in Fig. 3b) due to the presence of
methanol in the mobile phase. Since this methoxy group at
C11 is not relevant in the context of porothramycin biosyn-
thesis, we consider the imine form (see Fig. 1) to be the parent
compound as has been recommended (Gerratana 2012).
Discussion
The assignment of the analyzed gene cluster to porothramycin
biosynthesis
Prior to discussion of individual gene functions, the assign-
ment of the whole gene cluster to the final compound,
porothramycin, should be solved. The primers for analysis
of S. albus chromosomal DNA and cosmid library were
designed based on the sequences of ORF14, ORF22, and
ORF23 from anthramycin biosynthesis and respective
Table 3 Comparison of nonribosomal codes and the overall identity of A-domains activating derivatives of anthranilate (A) and branched L-proline (B)
involved in biosynthesis of PBDs
NRPS module 235 236 239 278 299 301 322 330 331 517 % of identity
A) Por20 A A T H L S A T L K 73
ORF21 A A T N I S A A L K 100
SibE A A T N I S A A L K 48
B) Por21 D V L Y Y T A L C K 71
ORF22 D V L Y Y T A L V K 100
SibD D V M F Y T A L V K 42
Amino acid positions are numbered at the top according to the PheA, A-domain of GrsA (Conti et al. 1997). Amino acid residues in porothramycin A-
domains differing from anthramycin ones are marked in gray. The percentage of overall NRPS module identity to anthramycin NRPS modules (ORF21,
ORF22) was estimated by BlastX analysis.
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homologous genes from sibiromycin, and in case of ORF14
also tomaymycin and lincomycin biosyntheses. Even so, no
additional sequences except for those corresponding to the
analyzed and published gene cluster HQ872605 were identi-
fied. The analysis of S. albus subsp. albus (ATCC 39897)
cultivation media accordingly revealed the single main prod-
uct structurally corresponding to porothramycin and several
minor products corresponding to predicted porothramycin
biosynthesis pathway if one or two methylation steps were
omitted. Thinking about hypothetical presence of other PBD
coding gene cluster in S. albus subsp. albus (ATCC 39897), it
is important to note that the genome of taxon belonging to the
identical species, S. albus J1074, was already fully sequenced.
Although its five putative biosynthetic gene clusters contain
one or multiple NRPS coding genes, none of them exhibit
similarity to any PBD coding gene.
Regardless the clear evidence based on the gene inactiva-
tion is absent, the above-mentioned data together provide
indirect but fairly strong evidence that the presence of addi-
tional PBD biosynthetic gene cluster is highly improbable in
the S. albus subsp. albus (ATCC 39897) genome.
Biosynthesis of 3-hydroxyanthranilic acid
In anthramycin and sibiromycin biosynthesis, the 3-
hydroxyanthranilic acid results from kynurenine pathway
(Fig. 4) catalyzed by homologous sets of four enzymes (Li
et al. 2009b). Porothramycin gene cluster encodes three of
them indicating the expected use of kynurenine pathway.
However, the gene homologous to orf17/sibP encoding
TDO catalyzing initial step of the pathway is missing. As
the kynurenine pathway in primary metabolism represents a
major route of tryptophan catabolism, even for streptomycetes
(Zummo et al. 2012; Kurnasov et al. 2003), one can expect the
use of primary metabolic TDO for this reaction. The possible
employment of a primary metabolic TDO in the secondary
metabolite biosynthesis was described for daptomycin biosyn-
thesis where the residual antibiotic production was observed
even after deletion of appropriate TDO encoding the cluster
gene (Baltz et al. 2010). The residual antibiotic production
was explained by the expression of alternative, primary met-
abolic TDO. In S. albus J1074 genome, the primary metabo-






















analysis of S. albus culture broth
reveals porothramycin. aMass
spectrum of the porothramycin
methoxy form, b CID mass
spectrum (fragmentation pattern),
c UV spectrum
Fig. 4 Proposed biosynthetic pathway for anthranilate moiety. Appropriate enzymes are marked: POR for porothramycin, Sib for sibiromycin, andORF
for anthramycin biosynthesis
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number CP004370.1). The relevant protein in producing
strain S. albus subsp. albus (ATCC 39897) could thus serve
this function in porothramycin biosynthesis.
Dehydroproline acryl-(N′,N ′-dimethyl)amide biosynthesis
The branched proline derivative moiety of porothramycin
differs from that of anthramycin only in the additional
dimethylation on the amide group of the side chain. Besides
the specific methyltransferase gene (por25, discussed later),
the set of biosynthetic genes should fully resemble the
anthramycin one. Accordingly, in the porothramycin biosyn-
thetic gene cluster, there was identified a full set of six genes
(por10, por11, and por13 to por16) with high-sequence sim-
ilarity not only to anthramycin biosynthetic genes (Table 2)
but also to six genes involved in biosynthesis of 4-propyl-L-
proline precursor of lincomycin (GenBank accession number
EU124663, Koberska et al. 2008) and genes assigned to
branched proline derivative biosynthesis from sibiromycin
and tomaymycin gene clusters (Fig. 5). The similarity is not
surprising considering already described common origin of
branched proline derivative precursors in both groups of nat-
ural compounds (Hu et al. 2007). In accordance with the
structural similarity of porothramycin and anthramycin, also
por12 coding for a putative FAD oxidoreductase has its coun-
terpart in the anthramycin biosynthesis (orf7).
However, considering the remaining four anthramycin
genes (orf1–4) coding for putative amidotransferase (orf1),
aldehyde dehydrogenase (orf2), alcohol dehydrogenase
(orf3), and cytochrome P450 hydroxylase (orf4), respectively,
only orf1 and orf4 have their homologs in the porothramycin
biosynthesis (por8 and por9). We suppose that the candidate
genes coding for alternative enzymes catalyzing the two miss-
ing oxidation steps in the proposed biosynthetic pathway
could be por23 and por27, specific for porothramycin gene
cluster only. The product of gene por23 exhibits 76 % identity
to putative FMNH2-dependent monooxygenase from
Rhodococcus wratislaviensis (WP_005567976), and product
of por27 is 73 % identical to a putative flavin-containing
monooxygenase from Saccharomonospora azurea
(WP_005445166). Both monooxygenase genes are highly
conserved among bacteria but are not frequently found in
streptomycetes.
According to BlastX analysis, the gene por1 exhibits high
similarity to NADPH-dependent FMN reductases. Many
FMN-dependent two-component monooxygenase systems,
consisting of NADPH-dependent FMN reductase and
FMNH2-dependent monooxygenase, have been described,
capable of catalyzing variety of different reactions including
oxidation of aromatic and polycyclic compounds or long-
chain alkanes (for review see Ellis 2010).We thus hypothesize
the product of por1 to provide a reduced FMN for FMNH2-
dependent monooxygenase encoded by por23 and/or por27.
We realize that without inactivation of appropriate genes in
the porothramycin producing strain, the proposed alternative
mechanism of branched proline derivative side-chain oxida-
tion remains speculative. The employment of oxidoreduc-
tase(s) out of the gene cluster cannot be excluded. Another
speculative role of the Por1+Por23+Por27 protein set could
be the function equivalent to missing TDO (homologous to
ORF17 from anthramycin biosynthesis), i.e. an oxidative ring
opening of tryptophan, the first biosynthetic step of anthrani-
late moiety biosynthesis. Finally, regarding positions of por1
and por27 just at the estimated borders of the gene cluster, we
cannot exclude also the possibility that those genes are not
involved in the porothramycin biosynthesis at all.
Methyltransferase genes
The only difference between porothramycin and anthramycin
structures is in the modification of core structure by methyl
groups (Fig. 1). Accordingly, in the porothramycin gene clus-
ter, two specific methyltransferase genes were identified. The
gene por25 codes for a protein exhibiting high similarity to
aminomethyltransferases. We propose that its product is re-
sponsible for the dimethylation of the amide group of the
Fig. 5 Proposed biosynthetic pathway of dehydroproline acryl-(N′,N′-
dimethyl)amide moiety. The compound in frame is supposed to be the
subject of condensation reaction. The following side chain modifications
thus occur probably already on the condensed PBD core structure. Ap-
propriate enzymes are marked: POR for porothramycin, Sib for
sibiromycin, Lmb for lincomycin, and ORF for anthramycin biosynthesis
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branched proline derivative moiety. The gene por26 codes for
putative O-methyltransferase, which possibly methylates the
C-9 hydroxyl of porothramycin.
The presence of the third methyltransferase gene por18
was not expected and cannot be easily explained. Por18 is
homologous to ORF19 and SibL from anthramycin and
sibiromycin gene cluster, respectively which are proposed to
methylate the C-8 position of aromatic ring of appropriate
PBD. However, the methylation of C-9 hydroxyl and not
C-8 of aromatic ring was previously demonstrated in the
structure of porothramycin (Tsunakawa et al. 1988). In this
paper, we confirmed by UHPLC-DAD-MS analysis of
S. albus culture broth the production of PBD compound with
characteristics corresponding to porothramycin (Fig. 3). The
fragmentation pattern corresponds to the compound with only
one methylation on the anthranilate moiety. Even though the
analysis does not allow determining which particular position
of the moiety is methylated, we can exclude the methylation of
both the positions, C-9 hydroxyl and C-8, at once. Summa-
rized, the Por18 methylation activity seems not to be
employed in porothramycin biosynthesis. The sequence anal-
ysis of por18 locus did not reveal any apparent reason: The
ORF is complete; the putative protein product exhibits high
similarity to ORF19 and SibL; and the gene has a fair Shine-
Dalgarno sequence. The regulation of gene expression could
possibly explain this missing activity.
Prediction of condensation reaction substrates
It is in question, if the authentic substrate of the por12 is the
compound in frame in Fig. 5, or rather already condensed
PBD core structure, i.e. which branched proline derivative
precursor is condensed with the anthranilate building unit.
According to high conservation of nonribosomal codes of
Por21/ORF22/SibD activating appropriate proline derivative
precursors, the activation of identical or highly similar sub-
strates seems to be more probable. Thus, we suppose the
condensation step to occur early in the biosynthesis, probably
before Por12 action. The further pathway-specific modifica-
tions of proline moiety probably take part on the condensed
PBD core structure. On the other hand, three differences were
found between nonribosomal codes of otherwise closely re-
lated Por20 and ORF21. Analogical situation was described in
biosynthesis of lincosamides, lincomycin, and celesticetin
(Kadlcik et al. 2013). Respective A-domains LmbC and CcbC
exhibit the highest overall mutual homology but radically
differ in the nonribosomal codes.Whereas L-proline activating
CcbC fulfills the L-proline consensus, LmbC that was proved
to activate 4-propyl-L-proline differs in five amino acid resi-
dues. In the case of PBD biosynthesis, the difference of Por20
from both ORF21/SibE nonribosomal codes indicates that
anthranilate precursor in porothramycin biosynthesis is not
identical with the antramycin/sibiromycin biosynthetic
pathway. As anthranilate moieties are differently modified in
final compounds (methylation of C-8 in anthramycin and
sibiromycin vs methylation of hydroxyl at C-9 in
porothramycin), we predict that the respective anthranilate
precursors enter the condensation already appropriately mod-
ified. Summarized we suppose that in porothramycin bio-
synthesis, the methylation of anthranilate unit catalyzed
by Por26 occurs prior the condensation reaction, while
modifications of branched proline derivative starting
probably with a reaction catalyzed by Por12 occurs on
already condensed PBD core.
Other porothramycin-specific genes
The BlastX analysis of the porothramycin gene cluster re-
vealed also three other porothramycin-specific genes: two
putative regulatory genes por4 and por22 and por24 encoding
putative glutamine synthetase. Glutamine synthetases are
ubiquitous enzymes essential for nitrogen metabolism cata-
lyzing the condensation of ammonium and glutamate to form
glutamine. Among others, they participate also in the biosyn-
thesis of L-tryptophan, the starting compound of 3-
hydroxyanthranilic acid biosynthesis. The product of por24
thus could possibly act to enhance the intracellular level of L-
tryptophane, available for porothramycin biosynthesis. More-
over, por22 is a putative regulatory gene, in which product
resembles the highest similarity to NmrA family proteins,
known to participate in controlling nitrogen metabolism
(Andrianopoulos et al. 1998). The putative product of remain-
ing gene por4 exhibits the highest sequence similarity to
DeoR family transcriptional regulators.
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